Sunshine Biopharma Inc (NASDAQ:SBFM) has a beta value of -1.00 and has seen 0.79 million shares traded in the recent trading session. The company, currently valued at $5.84M, closed the recent trade at $2.92 per share which meant it gained $0.48 on the day or 19.67% during that session. The SBFM stock price is -21721.92% off its 52-week high price of $637.20 and 27.74% above the 52-week low of $2.11. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.85 million shares traded. The 3-month trading volume is 591.07K shares.
Sunshine Biopharma Inc (NASDAQ:SBFM) trade information
Sporting 19.67% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SBFM stock price touched $2.92 or saw a rise of 3.95%. Year-to-date, Sunshine Biopharma Inc shares have moved -99.46%, while the 5-day performance has seen it change 28.07%. Over the past 30 days, the shares of Sunshine Biopharma Inc (NASDAQ:SBFM) have changed -1.02%. Short interest in the company has seen 0.37 million shares shorted with days to cover at 4.13.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sunshine Biopharma Inc (SBFM) estimates and forecasts
The company’s shares have lost -76.98% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 83.04%.
1 analysts offering their estimates for the company have set an average revenue estimate of 15.5M for the current quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 73.50% over the past 5 years.
SBFM Dividends
Sunshine Biopharma Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Sunshine Biopharma Inc (NASDAQ:SBFM)’s Major holders
Insiders own 0.23% of the company shares, while shares held by institutions stand at 1.84% with a share float percentage of 1.85%. Investors are also buoyed by the number of investors in a company, with Sunshine Biopharma Inc having a total of 11.0 institutions that hold shares in the company.
